Literature DB >> 8219254

An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer.

S P Lehrer1, R K Schmutzler, J M Rabin, B S Schachter.   

Abstract

We previously identified a polymorphism in the human estrogen receptor gene. In a preliminary study on women with estrogen receptor positive (ER+) breast tumors, we found that the presence of the rarer of the two alleles, the B' allele, is correlated with a history of spontaneous abortion. Because that study evaluated only women with estrogen receptor positive (ER+) breast cancer, it was unknown whether the observed correlation was restricted to the cancer group or was independent of breast cancer. We have now extended our analysis to include not only additional women with ER+ breast cancer, but also those with estrogen receptor negative (ER-) breast cancer and women without cancer. Results of the current study continue to show an association between the B' allele and a history of spontaneous abortion in the ER+ breast cancer group. There was no such correlation either in the ER- breast cancer group or in the group without cancer. Also, we continue to observe, in the ER+ breast cancer group, a significantly higher concentration of ER protein in tumors from homozygous wild type women (genotype BB), than in the tumors from women who are heterozygous for the rarer allele (genotype BB'). We conclude that the combination of spontaneous abortion and the BB' ER genotype may be a marker for breast cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219254     DOI: 10.1007/bf00689690

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  13 in total

1.  Chemoprevention for breast cancer: are we ready?

Authors:  D T Kiang
Journal:  J Natl Cancer Inst       Date:  1991-04-03       Impact factor: 13.506

Review 2.  Breast cancer (3).

Authors:  J R Harris; M E Lippman; U Veronesi; W Willett
Journal:  N Engl J Med       Date:  1992-08-13       Impact factor: 91.245

3.  Identification of a variant form of the human estrogen receptor with an amino acid replacement.

Authors:  T Garcia; M Sanchez; J L Cox; P A Shaw; J B Ross; S Lehrer; B Schachter
Journal:  Nucleic Acids Res       Date:  1989-10-25       Impact factor: 16.971

4.  Familial susceptibility to breast cancer: a complex inheritance.

Authors:  N Andrieu; F Clavel; F Demenais
Journal:  Int J Cancer       Date:  1989-09-15       Impact factor: 7.396

5.  Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy.

Authors:  V C Jordan; M K Lababidi; S Langan-Fahey
Journal:  J Natl Cancer Inst       Date:  1991-04-03       Impact factor: 13.506

6.  Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.

Authors:  L E Rutqvist; B Cedermark; U Glas; A Mattsson; L Skoog; A Somell; T Theve; N Wilking; J Askergren; M L Hjalmar
Journal:  J Natl Cancer Inst       Date:  1991-09-18       Impact factor: 13.506

7.  Incidence of an estrogen receptor polymorphism in breast cancer patients.

Authors:  R K Schmutzler; M Sanchez; S Lehrer; C A Chaparro; C Phillips; J Rabin; B Schachter
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

8.  Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception.

Authors:  J L Mills; J L Simpson; S G Driscoll; L Jovanovic-Peterson; M Van Allen; J H Aarons; B Metzger; F R Bieber; R H Knopp; L B Holmes
Journal:  N Engl J Med       Date:  1988-12-22       Impact factor: 91.245

9.  Incidence of early loss of pregnancy.

Authors:  A J Wilcox; C R Weinberg; J F O'Connor; D D Baird; J P Schlatterer; R E Canfield; E G Armstrong; B C Nisula
Journal:  N Engl J Med       Date:  1988-07-28       Impact factor: 91.245

10.  Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer.

Authors:  S Lehrer; M Sanchez; H K Song; J Dalton; E Levine; P Savoretti; S N Thung; B Schachter
Journal:  Lancet       Date:  1990-03-17       Impact factor: 79.321

View more
  5 in total

1.  Androgen receptor trinucleotide polymorphism in leiomyoma.

Authors:  Yao-Yuan Hsieh; Chi-Chen Chang; Fuu-Jen Tsai; Cheng-Chieh Lin; Lian-Shun Yeh; Ching-Tien Peng
Journal:  J Assist Reprod Genet       Date:  2004-12       Impact factor: 3.412

2.  The haplotypes GCA and ACA in ESR1 gene are associated with the susceptibility of recurrent spontaneous abortion (RSA) in Chinese Han: A case-control study and meta-analysis.

Authors:  Liang Tang; Qin Xiang; Ju Xiang; Jianming Li
Journal:  Medicine (Baltimore)       Date:  2022-05-27       Impact factor: 1.817

3.  Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations.

Authors:  Masahiro Sasaki; Yuichiro Tanaka; Noriaki Sakuragi; Rajvir Dahiya
Journal:  Eur J Clin Pharmacol       Date:  2003-08-16       Impact factor: 2.953

4.  Identification of thyroid carcinoma related genes with mRMR and shortest path approaches.

Authors:  Yaping Xu; Yue Deng; Zhenhua Ji; Haibin Liu; Yueyang Liu; Hu Peng; Jian Wu; Jingping Fan
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

5.  The AGT Haplotype of the ESR2 Gene Containing the Polymorphisms rs2077647A, rs4986938G, and rs1256049T Increases the Susceptibility of Unexplained Recurrent Spontaneous Abortion in Women in the Chinese Hui Population.

Authors:  Dawei Tang; Junhua Bao; Gang Bai; Miaomiao Hao; Rui Jin; Fang Liu
Journal:  Med Sci Monit       Date:  2020-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.